Imperial College London

ProfessorTimothyHallett

Faculty of MedicineSchool of Public Health

Professor of Global Health
 
 
 
//

Contact

 

+44 (0)20 7594 1150timothy.hallett

 
 
//

Location

 

School of Public HealthWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{de:2020:10.1371/journal.pone.0237525,
author = {de, Villiers MJ and Gamkrelidze, I and Hallett, TB and Nayagam, S and Razavi, H and Razavi-Shearer, D},
doi = {10.1371/journal.pone.0237525},
journal = {PLoS One},
pages = {1--16},
title = {Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models},
url = {http://dx.doi.org/10.1371/journal.pone.0237525},
volume = {15},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Hepatitis B is a global epidemic that requires carefully orchestrated vaccination initiatives in geographical regions of medium to high endemicity to reach the World Health Organization’s elimination targets by 2030. This study compares two widely-used deterministic hepatitis B models—the Imperial HBV model and the CDA Foundation’s PRoGReSs—based on their predicted outcomes in four countries. The impact of scaling up of the timely birth dose of the hepatitis B vaccine is also investigated. The two models predicted largely similar outcomes for the impact of vaccination programmes on the projected numbers of new cases and deaths under high levels of the infant hepatitis B vaccine series. However, scenarios for the scaling up of the infant hepatitis B vaccine series had a larger impact in the PRoGReSs model than in the Imperial model due to the infant vaccine series directly leading to the reduction of perinatal transmission in the PRoGReSs model, but not in the Imperial model. Meanwhile, scaling up of the timely birth dose vaccine had a greater impact on the outcomes of the Imperial hepatitis B model than in the PRoGReSs model due to the greater protection that the birth dose vaccine confers to infants in the Imperial model compared to the PRoGReSs model. These differences underlie the differences in projections made by the models under some circumstances. Both sets of assumptions are consistent with available data and reveal a structural uncertainty that was not apparent in either model in isolation. Those relying on projections from models should consider outputs from both models and this analysis provides further evidence of the benefits of systematic model comparison for enhancing modelling analyses.
AU - de,Villiers MJ
AU - Gamkrelidze,I
AU - Hallett,TB
AU - Nayagam,S
AU - Razavi,H
AU - Razavi-Shearer,D
DO - 10.1371/journal.pone.0237525
EP - 16
PY - 2020///
SN - 1932-6203
SP - 1
TI - Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
T2 - PLoS One
UR - http://dx.doi.org/10.1371/journal.pone.0237525
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000561393800033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237525
UR - http://hdl.handle.net/10044/1/91801
VL - 15
ER -